tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Financial Statements

199 Followers

Atea Pharmaceuticals Financial Overview

Atea Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.63; its P/E ratio is -2.45; Atea Pharmaceuticals is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -32.92M$ -27.93M$ -41.57M$ -39.90M$ -16.28M
EBITDA$ -37.13M$ -31.52M$ -44.55M$ -40.16M$ -16.18M
Net Income Common Stockholders$ -33.14M$ -28.18M$ -35.47M$ -34.43M$ -8.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 595.13M$ 608.06M$ 620.49M$ 646.71M$ 664.98M
Total Assets$ 608.08M$ 626.03M$ 636.53M$ 666.71M$ 686.58M
Total Debt$ 2.58M$ 2.77M$ 2.94M$ 3.12M$ 3.30M
Net Debt$ -592.54M$ -605.30M$ -617.54M$ -643.59M$ -661.68M
Total Liabilities$ 26.34M$ 23.68M$ 19.95M$ 26.14M$ 23.39M
Stockholders Equity$ 581.73M$ 602.35M$ 618.18M$ 640.57M$ 663.19M
Cash Flow-
Free Cash Flow$ -17.59M$ -16.12M$ -29.85M$ -21.55M$ -21.26M
Operating Cash Flow$ -17.59M$ -16.12M$ -29.85M$ -21.55M$ -21.24M
Investing Cash Flow$ -58.51M$ 46.56M$ 24.48M$ 33.49M$ -486.98M
Financing Cash Flow$ 92.00K-$ 165.00K-$ 147.00K
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

Atea Pharmaceuticals Debt to Assets

Atea Pharmaceuticals Cash Flow

Atea Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis